Entropy Technologies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Entropy Technologies’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,844	Closed	-$239K	–	969
2024 Q2	$239K	Sell	5,844 -10,287	-64%	-$428K	0.03%	558
2024 Q1	$682K	Buy	+16,131	New	+$678K	0.07%	373

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Entropy Technologies's CERE Position: Q3 2024 in Review

Entropy Technologies sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 5,844 shares — an estimated $239K sold.

Entropy Technologies first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $682K in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Entropy Technologies reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Entropy Technologies sold 5,844 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $239K.
Entropy Technologies first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
Entropy Technologies's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $682K in Q1 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Entropy Technologies's 13F filing for Q3 2024, filed 4 Nov 2024.